188 related articles for article (PubMed ID: 14512913)
1. Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States?
Fleischer AB; Simpson JK; McMichael A; Feldman SR
J Am Acad Dermatol; 2003 Oct; 49(4):662-6. PubMed ID: 14512913
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005-2014.
Rogers AT; Semenov YR; Kwatra SG; Okoye GA
J Dermatolog Treat; 2018 May; 29(3):287-289. PubMed ID: 28831837
[TBL] [Abstract][Full Text] [Related]
3. Association of Race/Ethnicity and Sex With Differences in Health Care Use and Treatment for Acne.
Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
JAMA Dermatol; 2020 Mar; 156(3):312-319. PubMed ID: 32022834
[TBL] [Abstract][Full Text] [Related]
4. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.
Landis ET; Levender MM; Davis SA; Feneran AN; Gerancher KR; Feldman SR
J Dermatolog Treat; 2012 Aug; 23(4):272-7. PubMed ID: 22380867
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin Monitoring Trends: A National Survey of Dermatologists.
Hobson JG; Cunningham MJ; Lesiak K; Lester EB; Tegeder AR; Zeeck E; Hugh JM; Lin JH
J Drugs Dermatol; 2017 Jun; 16(6):557-564. PubMed ID: 28686773
[TBL] [Abstract][Full Text] [Related]
6. Acne therapy. Medication use and sources of care in office-based practice.
Stern RS
Arch Dermatol; 1996 Jul; 132(7):776-80. PubMed ID: 8678569
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic inertia during isotretinoin treatment of juvenile acne by dermatologists, paediatricians and general practitioners.
Mahé E; Werner A; Cret L; Salinier C; Guellich A; Maruani A; Assathiany R;
Ann Dermatol Venereol; 2023 Mar; 150(1):39-45. PubMed ID: 36642678
[TBL] [Abstract][Full Text] [Related]
8. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
Gollnick HP; Graupe K; Zaumseil RP
Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
[TBL] [Abstract][Full Text] [Related]
9. Roaccutane treatment guidelines: results of an international survey.
Cunliffe WJ; van de Kerkhof PC; Caputo R; Cavicchini S; Cooper A; Fyrand OL; Gollnick H; Layton AM; Leyden JJ; Mascaró JM; Ortonne JP; Shalita A
Dermatology; 1997; 194(4):351-7. PubMed ID: 9252756
[TBL] [Abstract][Full Text] [Related]
10. Coprescription of Isotretinoin and Tetracyclines for Acne is Rare: An Analysis of the National Ambulatory Medical Care Survey.
Reserva J; Adams W; Perlman D; Vasicek B; Joyce C; Tung R; Swan J
J Clin Aesthet Dermatol; 2019 Oct; 12(10):45-48. PubMed ID: 32038749
[No Abstract] [Full Text] [Related]
11. Severe acne infantum successfully treated with isotretinoin.
Torrelo A; Pastor MA; Zambrano A
Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin (roaccutane) usage--a South African consensus guideline. National Dermatology Working Group.
S Afr Med J; 1997 Oct; 87(10 Pt 2):1410-3. PubMed ID: 11496385
[TBL] [Abstract][Full Text] [Related]
13. [Second joint position paper: Use of isotretinoin in severe acne].
Gómez-Flores M; Poletti-Vázquez DE; García-Hidalgo L; Fierro-Arias L; Herz-Ruelas M; Garza-Gómez J; Rosas-Ortiz JF
Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):441-446. PubMed ID: 30777411
[TBL] [Abstract][Full Text] [Related]
14. Acne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance.
Patel K; Nole KB; Fleischer A
J Drugs Dermatol; 2021 Jun; 20(6):648-651. PubMed ID: 34076393
[TBL] [Abstract][Full Text] [Related]
15. Differences in acne therapy prescribing patterns between dermatologists and pediatricians: A population-based study.
Jones ME; Pourali SP; Kohn AH; Gutierrez Y; Rajkumar JR; Armstrong AW
Pediatr Dermatol; 2021 Sep; 38(5):1150-1156. PubMed ID: 34514637
[TBL] [Abstract][Full Text] [Related]
16. Dermatologists' attitudes, prescription, and counseling patterns for isotretinoin: a questionnaire-based study.
Nagler AR; Orlow SJ
J Drugs Dermatol; 2015 Feb; 14(2):184-9. PubMed ID: 25689814
[TBL] [Abstract][Full Text] [Related]
17. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?
Azoulay L; Oraichi D; Bérard A
Eur J Clin Pharmacol; 2006 Aug; 62(8):667-74. PubMed ID: 16791584
[TBL] [Abstract][Full Text] [Related]
18. Medication and medical service utilization for acne 1995-1998.
Stern RS
J Am Acad Dermatol; 2000 Dec; 43(6):1042-8. PubMed ID: 11100021
[TBL] [Abstract][Full Text] [Related]
19. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013.
Barbieri JS; James WD; Margolis DJ
J Am Acad Dermatol; 2017 Sep; 77(3):456-463.e4. PubMed ID: 28676330
[TBL] [Abstract][Full Text] [Related]
20. Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature.
Bari O; Paravar T
Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
